Comparison of the Binding Activities of Some Drugs on α2A, α2B and α2C‐Adrenoceptors and Non‐Adrenergic Imidazoline Sites in the Guinea Pig

Simultaneous computer modelling of control and guanfacine-masked [ 3 H]-MK 912 saturation curves as well as guanfacine competition curves revealed that both α 2A - and α 2C -adrenoceptor subtypes were present in the guinea pig cerebral cortex. The K d value of [ 3 H]-MK 912 determined for the α 2A -subtype was 403 pM and for the α 2C -subtype 79.8 pM; the receptor sites showing capacities 172 and 19.5 fmol/mg protein, respectively. The K d s of guanfacine were 20 and 880 nM for the α 2A - and α 2C -adrenoceptor, respectively. In the guinea pig kidney [ 3 H]-MK 912 bound to a single saturable site with K d 8.34 nM and capacity 285 fmol/mg protein, the site showing pharmacological properties like an α 2B -adrenoceptor. Binding constants of 22 compounds for the three guinea pig α 2 -adrenoceptor subtypes were determined by com puter modelling competition curves using for the cerebral cortex a «3-curve assay», for the kidney an «1-curve assay», and using [ 3 H]-MK 912 as labelled ligand. Of the tested drugs guanfacine and BRL 44408 were found to be clearly α 2A -selective. Spiroxatrine, yohimbine, rauwolscine and WB 4101, as well as [ 3 H]-MK 912 itself, were found to be α 2C -selective. The most selective compounds for α 2B -adrenoceptors, when compared to α 2A -adrenoceptors, were ARC 239 and prazosin. In the guinea pig kidney [ 3 H]-p-aminoclonidine bound to α 2 -adrenoceptors as well as to non-adrenergic imidazoline sites. The α 2 -adrenoceptors could be completely blocked using 10 μM (-)-adrenaline without the non-adrenergic sites being affected. During these conditions the analysis of combined saturation and competition studies using labelled and unlabelled p-aminoclonidine with computer modelling revealed that the ligand labelled two different sites with was of 310 and 47,000 nM, respectively. Competition curves of 16 compounds for the non-adrenergic [ 3 H]-p-aminoclonidine sites were shallow and resolved into two-site fits. For the high affinity [ 3 H]-p-aminoclonidine site the highest affinities were shown by 1-medetomidine, UK-14,304, guanabenz and detomidine; the K d s of these drugs ranging 26-72 nM. All drugs tested showed low but varying affinities for the low affinity [ 3 H]-p-aminoclonidine site. These data indicated that the [ 3 H]-p-aminoclonidine binding sites of the guinea pig kidney are grossly different from the [ 3 H]-idazoxan binding I 2 -receptors previously demonstrated also to be present in the guinea pig kidney

[1]  J. Wikberg,et al.  Further Characterization of the Guinea Pig Cerebral Cortex Idazoxan Receptor: Solubilization, Distinction from the Imidazole Site, and Demonstration of Cirazoline as an Idazoxan Receptor‐Selective Drug , 1990, Journal of neurochemistry.

[2]  J. Reid,et al.  A comparison of the haemodynamic and behavioural effects of moxonidine and clonidine in normotensive subjects. , 1992, British journal of clinical pharmacology.

[3]  T. Ishikawa,et al.  Binding of [3H]p-aminoclonidine to two sites, α2-adrenoceptors and imidazoline binding sites: distribution of imidazoline binding sites in rat brain , 1990, Brain Research.

[4]  J. Wikberg,et al.  Medetomidine stereoisomers delineate two closely related subtypes of idazoxan (imidazoline) I-receptors in the guinea pig. , 1991, European journal of pharmacology.

[5]  D. Langin,et al.  Binding of [3H]idazoxan and of its methoxy derivative [3H] RX821002 in human fat cells: [3H]idazoxan but not [3H] RX821002 labels additional non-alpha 2-adrenergic binding sites. , 1990, Molecular pharmacology.

[6]  P. Insel,et al.  Are there multiple imidazoline binding sites? , 1989, Trends in pharmacological sciences.

[7]  D. Reis,et al.  Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area. , 1991, European journal of pharmacology.

[8]  J. Wikberg,et al.  Rat Spinal Cord α2‐Adrenoceptors are of the α2A‐Subtype: Comparison with α2A‐ and α2B‐Adrenoceptors in Rat Spleen, Cerebral Cortex and Kidney Using 3H‐RX821002 Ligand Binding , 1991 .

[9]  D. Reis,et al.  Hypotensive action of clonidine analogues correlates with binding affinity at imidazole and not alpha‐2-adrenergic receptors in the rostral ventrolateral medulla , 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[10]  D. Reis,et al.  Effects of clonidine and other imidazole-receptor binding agents on second messenger systems and calcium influx in bovine adrenal chromaffin cells. , 1991, Biochemical pharmacology.

[11]  M. Dontenwill,et al.  L 2 ‐ FROM THE α2‐ADRENOCEPTORS TO THE IMIDAZOLINE PREFERRING RECEPTORS , 1992 .

[12]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[13]  C. A. Guyer,et al.  An aspartate conserved among G-protein receptors confers allosteric regulation of alpha 2-adrenergic receptors by sodium. , 1990, The Journal of biological chemistry.

[14]  D. Reis,et al.  Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. , 1990, The Journal of pharmacology and experimental therapeutics.

[15]  M. Dontenwill,et al.  Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit , 1990, British journal of pharmacology.

[16]  William R. Pearson,et al.  Molecular characterization of α1- and α2-adrenoceptors , 1991 .

[17]  D. Langin,et al.  [3H]Idazoxan binding at non-α2-adrenoceptors in rabbit adipocyte membranes , 1989 .

[18]  A. Parini,et al.  Effect of imidazolines on Na+ transport and intracellular pH in renal proximal tubule cells. , 1990, Biochimica et biophysica acta.

[19]  D. Bylund,et al.  Molecular determinants of the alpha-2D adrenergic receptor subtype. , 1993, Life sciences.

[20]  J. Wikberg,et al.  Evidence that drug binding to non-adrenergic [3H]-idazoxan binding sites (I-receptors) occurs to interacting or interconvertible affinity forms of the receptor. , 1992, Pharmacology & toxicology.

[21]  R. Graham,et al.  Characterization of an imidazoline/guanidinium receptive site distinct from the alpha 2-adrenergic receptor. , 1989, The Journal of biological chemistry.

[22]  J. Wikberg High affinity binding of idazoxan to a non-catecholaminergic binding site in the central nervous system: description of a putative idazoxan-receptor. , 1989, Pharmacology & toxicology.

[23]  D. Reis,et al.  Characterization and visualization of clonidine-sensitive imidazole sites in rat kidney which recognize clonidine-displacing substance. , 1990, American journal of hypertension.

[24]  D. Reis,et al.  An endogenous substance with clonidine-like properties: selective binding to imidazole sites in the ventrolateral medulla , 1988, Brain Research.

[25]  J. Harrison,et al.  Pharmacological characterization of rat alpha 2-adrenergic receptors. , 1991, Molecular pharmacology.

[26]  F. Gonon,et al.  Selectivity of rilmenidine for the nucleus reticularis lateralis, a ventrolateral medullary structure containing imidazoline-preferring receptors. , 1991, European journal of pharmacology.

[27]  D. Langin,et al.  Discrimination between alpha 2-adrenoceptors and [3H]idazoxan-labelled non-adrenergic sites in rabbit white fat cells. , 1990, European journal of pharmacology.

[28]  D. Reis,et al.  L 3 ‐ IMIDAZOLINE RECEPTORS IN THE NERVOUS SYSTEM , 1992, Fundamental & clinical pharmacology.

[29]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[30]  J. Wikberg,et al.  Further evidence for the existence of two forms of alpha 2B-adrenoceptors in rat. , 1993, Pharmacology & toxicology.

[31]  M. Dontenwill,et al.  The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem. , 1989, European journal of pharmacology.

[32]  J. De Keyser,et al.  High affinity binding of 3H rauwolscine and 3H RX781094 to alpha 2 adrenergic receptors and non-stereoselective sites in human and rabbit brain cortex membranes. , 1989, Biochemical pharmacology.

[33]  J. Huff,et al.  [3H]L-657, 743 (MK-912): A new, high affinity, selective radioligand for brain α2-adrenoceptors , 1989 .

[34]  M. Dontenwill,et al.  New concepts on the central regulation of blood pressure. Alpha 2-adrenoceptors and "imidazoline receptors". , 1989, The American journal of medicine.

[35]  D. Reis,et al.  Clonidine binds to imidazole binding sites as well as alpha 2-adrenoceptors in the ventrolateral medulla. , 1987, European journal of pharmacology.

[36]  J. Wikberg,et al.  Delineation of three pharmacological subtypes of α2‐adrenoceptor in the rat kidney , 1991 .

[37]  H. Y. Kwa,et al.  Characterization of alpha-adrenoceptors participating in the central hypotensive and sedative effects of clonidine using yohimbine, rauwolscine and corynanthine. , 1981, European journal of pharmacology.

[38]  J. Wikberg,et al.  [3H]‐MK 912 binding delineates two α2‐adrenoceptor subtypes in rat CNS one of which is identical with the cloned pA2d α2‐adrenoceptor , 1992 .

[39]  J. Pégorier,et al.  Subcellular distribution of imidazoline-guanidinium-receptive sites in human and rabbit liver. Major localization to the mitochondrial outer membrane. , 1991, The Journal of biological chemistry.

[40]  J. Reid,et al.  Imidazole binding sites in rabbit kidney and forebrain membranes. , 1991, Journal of autonomic pharmacology.

[41]  P. Molinoff,et al.  International Union of Pharmacology nomenclature of adrenoceptors. , 1994, Pharmacological reviews.

[42]  G. Barsh,et al.  Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding. , 1992, Molecular pharmacology.

[43]  D. Atlas,et al.  Imidazoline-guanidinium receptive site in renal proximal tubule: asymmetric distribution, regulation by cations and interaction with an endogenous clonidine displacing substance. , 1990, The Journal of pharmacology and experimental therapeutics.

[44]  P. Gosse,et al.  [Rilmenidine, a new antihypertensive agent in the first line treatment of essential arterial hypertension. Multicenter double-blind study versus atenolol]. , 1991, Presse medicale.

[45]  H. Motulsky,et al.  [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site. , 1989, Molecular pharmacology.

[46]  D. Bylund Subtypes of α1‐ and α2‐adrenergic receptors , 1992 .

[47]  J. Wikberg,et al.  Delineation of rat kidney α2A- and α2B-adrenoeeptors with [3H]RX821002 radiollgand binding: computer modelling reveals that guanfacine is an α2A-selective compound , 1991 .